Work

OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: European Urology

DOI: 10.1016/j.eururo.2013.04.001

Authors: Christopher Chapple, Karl-Dietrich Sievert, Scott MacDiarmid, Vik Khullar, Piotr Radziszewski, Christopher Nardo, Catherine Thompson, Jihao Zhou, Cornelia Haag-Molkenteller

Institutions: Royal Hallamshire Hospital, University of Tübingen, Imperial College London, Medical University of Warsaw, Allergan (United States), Allergan (United Kingdom)

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Astellas Pharma US, American Medical Systems, Allergan

OpenAlex ID: W2043938107

FWCI: 38.59

Cites: 34

Cited by: 427

Related to: 10